Latest News

Date Title Topic
23 Oct 2017 Data Privacy in the Age of Big Data Bioethics, legal and economic issues - Personalised medicine
23 Oct 2017 ESMO Statement: ESMO Calls for Cancer Specific Targets to be Included in Non-Communicable Diseases' Global and National Agendas
20 Oct 2017 FDA Approves Axicabtagene Ciloleucel for Large B-Cell Lymphoma Haematologic malignancies - Cancer Immunology and Immunotherapy
20 Oct 2017 Annals of Oncology Press Release: Oral Sex and Smoking Increase Men’s Risk of Head and Neck Cancer But the Risk is Still Low, Making Screening for the Disease a Challenge
19 Oct 2017 Precision Medicine Experts Exploit Multiple Mutations to Improve Cancer Treatment Translational research - Personalised medicine
19 Oct 2017 New Ovarian Cancer Patient Guide Now Available!
19 Oct 2017 ESMO Press Release: First ESMO Award in Immuno-Oncology Goes to Laurence Zitvogel
Registration
18 Oct 2017 EMA Recommends Extension of Indications for Fulvestrant Breast cancer - Anticancer agents & Biologic therapy
17 Oct 2017 EMA Recommends Extension of Indications for Abiraterone Acetate Genitourinary cancers - Anticancer agents & Biologic therapy
16 Oct 2017 EMA Recommends Extension of Indications for Alectinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
13 Oct 2017 Paediatric, Adolescent, and Young Adult Survivors of Hodgkin’s Disease Face an Elevated Risk of Cardiovascular Disease Haematologic malignancies - Cancer in Special Situations
11 Oct 2017 Countdown to Launch of New EudraVigilance System Bioethics, legal and economic issues
09 Oct 2017 Exploring Opportunities for Collaboration Between Regulators and Healthcare Payers Bioethics, legal and economic issues
06 Oct 2017 NICE Issues Technology Appraisal Guidance for Brentuximab Vedotin Haematologic malignancies - Anticancer agents & Biologic therapy